Literature DB >> 32227233

Time to rename the middle child of heart failure: heart failure with mildly reduced ejection fraction.

Carolyn S P Lam1,2, Adriaan A Voors2, Ponikowski Piotr3, John J V McMurray4, Scott D Solomon5.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32227233     DOI： 10.1093/eurheartj/ehaa158

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  7 in total

Review 1.  Heart failure with mildly reduced ejection fraction: from diagnosis to treatment. Gaps and dilemmas in current clinical practice.

Authors:  Marta Cvijic; Yelena Rib; Suzana Danojevic; Crina Ioana Radulescu; Natia Nazghaidze; Panos Vardas
Journal:  Heart Fail Rev       Date:  2022-07-25       Impact factor: 4.654

Review 2.  Heart failure with mid-range or mildly reduced ejection fraction.

Authors:  Gianluigi Savarese; Davide Stolfo; Gianfranco Sinagra; Lars H Lund
Journal:  Nat Rev Cardiol       Date:  2021-09-06       Impact factor: 32.419

3.  Rationale and design of the preserved versus reduced ejection fraction biomarker registry and precision medicine database for ambulatory patients with heart failure (PREFER-HF) study.

Authors:  Andrew Abboud; Austin Nguonly; Asher Bean; Kemar J Brown; Roy F Chen; David Dudzinski; Neyat Fiseha; Melvin Joice; Davis Kimaiyo; Mackenzie Martin; Christy Taylor; Kevin Wei; Megan Welch; Daniel A Zlotoff; James L Januzzi; Hanna K Gaggin
Journal:  Open Heart       Date:  2021-10

4.  Left atrial strain predicts exercise capacity in heart failure independently of left ventricular ejection fraction.

Authors:  Caterina Maffeis; Andrea Rossi; Lorenzo Cannata; Camilla Zocco; Evgeny Belyavskiy; Aravind Kumar Radhakrishnan; Anna Feuerstein; Daniel Armando Morris; Elisabeth Pieske-Kraigher; Burkert Pieske; Frank Edelmann; Pier Luigi Temporelli
Journal:  ESC Heart Fail       Date:  2022-01-05

5.  Use of angiotensin receptor blocker is associated with improved 1 year mortality in heart failure with mid-range ejection fraction.

Authors:  Bin Wang; Lihua Zhang; Shuang Hu; Xueke Bai; Xi Li; Jing Li; Xin Zheng
Journal:  ESC Heart Fail       Date:  2021-02-22

6.  Urinary peptides in heart failure: a link to molecular pathophysiology.

Authors:  Tianlin He; Michaela Mischak; Andrew L Clark; Ross T Campbell; Christian Delles; Javier Díez; Gerasimos Filippatos; Alexandre Mebazaa; John J V McMurray; Arantxa González; Julia Raad; Rafael Stroggilos; Helle S Bosselmann; Archie Campbell; Shona M Kerr; Colette E Jackson; Jane A Cannon; Morten Schou; Nicolas Girerd; Patrick Rossignol; Alex McConnachie; Kasper Rossing; Joost P Schanstra; Faiez Zannad; Antonia Vlahou; William Mullen; Vera Jankowski; Harald Mischak; Zhenyu Zhang; Jan A Staessen; Agnieszka Latosinska
Journal:  Eur J Heart Fail       Date:  2021-05-07       Impact factor: 17.349

7.  Burden and Quality of Life Among Female and Male Patients with Heart Failure in Europe: A Real-World Cross-Sectional Study.

Authors:  Ana Filipa Fonseca; Raquel Lahoz; Clare Proudfoot; Stefano Corda; Emil Loefroth; James Jackson; Sarah Cotton; Rachel Studer
Journal:  Patient Prefer Adherence       Date:  2021-07-30       Impact factor: 2.711
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.